Sangamo Therapeutics, Inc. · NASDAQ:SGMO
Davis Gregory D sold 69,827 Sangamo Therapeutics, Inc. shares (Form 4)
Traded Apr 22, 2026 · Filed Apr 23, 2026
On Apr 22, 2026, Davis Gregory D (Head of Research & Technology) sold 69,827 Sangamo Therapeutics, Inc. shares at US$0.25 for US$17,457, leaving 115,284 shares. Filed Apr 23, 2026 (Form 4).
- Sold
- 69,827 shares
- Price
- US$0.25
- Value
- US$17,457
- Holding after
- 115,284 shares
- Trading plan
- No
- Role
- Head of Research & Technology
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Apr 22, 2026 | Common Stock | Sale | 69,827 | US$0.25 | 115,284 | Direct |
Source
Related
- Sangamo Therapeutics, Inc.
- Davis Gregory D
- Sangamo Therapeutics, Inc. shareholders
- Form 4 · Davis Gregory D · May 27, 2026
- Schedule 13G/A · Armistice Capital, LLC · Aug 14, 2026
- Form 4 · Jain Nikunj · May 27, 2026
- Form 4 · Dubois-Stringfellow Nathalie · May 27, 2026
- Form 4 · Willoughby Scott B. · May 27, 2026
- Form 4 · Macrae Sandy · May 27, 2026